Reuters logo
BRIEF-Bristol-Myers ‍announces data for Opdivo and Opdivo plus Yervoy in previously treated small cell lung cancer​
2017年10月16日 / 早上8点21分 / 1 个月前

BRIEF-Bristol-Myers ‍announces data for Opdivo and Opdivo plus Yervoy in previously treated small cell lung cancer​

Oct 16 (Reuters) - Bristol-Myers Squibb Co

* Bristol-Myers Squibb Co ‍announced data evaluating Opdivo (nivolumab) and Opdivo plus Yervoy (ipilimumab) in previously treated small cell lung cancer​

* Bristol-Myers squibb co says ‍in patients with high tmb who received opdivo plus yervoy, 62% were alive at one year​

* Bristol-Myers squibb co says ‍in patients with high tmb who received opdivo, 35% were alive at one year​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below